ELAVL1 and metabolic dysfunction-associated steatotic liver disease: In the context of MASLD, inflammation and tumorigenesis are exacerbated in hepatocyte- and cholangiocyte-specific HuR-deficient mice after 14 months of HFD-CD feeding [101].